Pulse Inhibition of Histone Deacetylases Induces Complete Resistance to Oxidative Death in Cortical Neurons without Toxicity and Reveals a Role for Cytoplasmic p21waf1/cip1 in Cell Cycle-Independent Neuroprotection

Histone deacetylase (HDAC) inhibitors are currently in human clinical trials as antitumor drugs because of their ability to induce cell dysfunction and death in cancer cells. The toxic effects of HDAC inhibitors are also apparent in cortical neurons in vitro, despite the ability of these agents to induce significant protection in the cells they do not kill. Here we demonstrate that pulse exposure of cortical neurons (2 h) in an in vitro model of oxidative stress results in durable neuroprotection without toxicity. Protection was associated with transcriptional upregulation of the cell cycle inhibitor, p21waf1/cip1, both in this model and in an in vivo model of permanent ischemia. Transgenic overexpression of p21waf1/cip1 in neurons can mimic the protective effect of HDAC inhibitors against oxidative stress-induced toxicity, including death induced by glutathione depletion or peroxide addition. The protective effect of p21waf1/cip1 in the context of oxidative stress appears to be unrelated to its ability to act in the nucleus to inhibit cell cycle progression. However, although p21waf1/cip1 is sufficient for neuroprotection, it is not necessary for HDAC inhibitor neuroprotection, because these agents can completely protect neurons cultured from p21waf1/cip1-null mice. Together these findings demonstrate (1) that pulse inhibition of HDACs in cortical neurons can induce neuroprotection without apparent toxicity; (2) that p21waf1/cip1 is sufficient but not necessary to mimic the protective effects of HDAC inhibition; and (3) that oxidative stress in this model induces neuronal cell death via cell cycle-independent pathways that can be inhibited by a cytosolic, noncanonical action of p21waf1/cip1.

[1]  Mitsuru Nenoi,et al.  Regulation of , 2004 .

[2]  Shile Huang,et al.  Negative Regulation of ASK1 by p21Cip1 Involves a Small Domain That Includes Serine 98 That Is Phosphorylated by ASK1 In Vivo , 2007, Molecular and Cellular Biology.

[3]  A. Chiarugi,et al.  Pharmacological Inhibition of Histone Deacetylases by Suberoylanilide Hydroxamic Acid Specifically Alters Gene Expression and Reduces Ischemic Injury in the Mouse Brain , 2006, Molecular Pharmacology.

[4]  M. Endres,et al.  Inhibition of histone deacetylation protects wild‐type but not gelsolin‐deficient neurons from oxygen/glucose deprivation , 2006, Journal of neurochemistry.

[5]  Barry Halliwell,et al.  Oxidative stress and neurodegeneration: where are we now? , 2006, Journal of neurochemistry.

[6]  D. Mann,et al.  The Intricacies of p21 Phosphorylation: Protein/Protein Interactions, Subcellular Localization and Stability , 2006, Cell cycle.

[7]  J. You,et al.  Histone deacetylase inhibitor apicidin induces cyclin E expression through Sp1 sites. , 2006, Biochemical and biophysical research communications.

[8]  C. Sen,et al.  Characterization of the potent neuroprotective properties of the natural vitamin E alpha-tocotrienol. , 2006, Journal of neurochemistry.

[9]  P. Marks,et al.  Histone deacetylase inhibitors: discovery and development as anticancer agents , 2005, Expert opinion on investigational drugs.

[10]  C. Sen,et al.  Neuroprotective Properties of the Natural Vitamin E &agr;-Tocotrienol , 2005, Stroke.

[11]  L. Greene,et al.  Bim Is a Direct Target of a Neuronal E2F-Dependent Apoptotic Pathway , 2005, The Journal of Neuroscience.

[12]  T. Duong,et al.  Effects of Intravenous Dimethyl Sulfoxide on Ischemia Evolution in a Rat Permanent Occlusion Model , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  M. Beal,et al.  Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents. , 2005, Current drug targets. CNS and neurological disorders.

[14]  人見 敏明 p15[INK4b] in HDAC inhibitor-induced growth arrest , 2005 .

[15]  K. Herrup,et al.  Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death , 2004, The Journal of Neuroscience.

[16]  L. Greene,et al.  B-Myb and C-Myb Play Required Roles in Neuronal Apoptosis Evoked by Nerve Growth Factor Deprivation and DNA Damage , 2004, The Journal of Neuroscience.

[17]  R. Ratan,et al.  Oxidative stress‐induced death in the nervous system: Cell cycle dependent or independent? , 2004, Journal of neuroscience research.

[18]  D. Chuang,et al.  Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction , 2004, Journal of neurochemistry.

[19]  J. Munro,et al.  Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. , 2004, Experimental cell research.

[20]  L. Ngo,et al.  Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Wade S. Smith Pathophysiology of focal cerebral ischemia: a therapeutic perspective. , 2004, Journal of vascular and interventional radiology : JVIR.

[22]  T. Sakai,et al.  p15INK4b in HDAC inhibitor‐induced growth arrest , 2003, FEBS letters.

[23]  Shile Huang,et al.  Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). , 2003, Molecular cell.

[24]  I. Reynolds,et al.  Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration , 2003, Journal of neurochemistry.

[25]  T. Murphy,et al.  Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress , 2003, The Journal of Neuroscience.

[26]  J. Julien,et al.  Cell Cycle Regulators in the Neuronal Death Pathway of Amyotrophic Lateral Sclerosis Caused by Mutant Superoxide Dismutase 1 , 2003, The Journal of Neuroscience.

[27]  Rajiv R. Ratan,et al.  Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Kuang-Hung Cheng,et al.  Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code , 2003, Annals of the New York Academy of Sciences.

[29]  Yue Xue,et al.  Association of JNK1 with p21waf1 and p53: Modulation of JNK1 activity , 2003, Molecular carcinogenesis.

[30]  C. Achim,et al.  Expression Patterns of Retinoblastoma Protein in Parkinson Disease , 2003, Journal of neuropathology and experimental neurology.

[31]  D. DeFranco,et al.  Prolonged Nuclear Retention of Activated Extracellular Signal-regulated Protein Kinase Promotes Cell Death Generated by Oxidative Toxicity or Proteasome Inhibition in a Neuronal Cell Line* , 2002, The Journal of Biological Chemistry.

[32]  David S. Park,et al.  Inhibition of Cyclin-Dependent Kinases Improves CA1 Neuronal Survival and Behavioral Performance after Global Ischemia in the Rat , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  K. Honn,et al.  12(S)-HETE, pleiotropic functions, multiple signaling pathways. , 2002, Advances in experimental medicine and biology.

[34]  L. Greene,et al.  Regulation of Neuronal Survival and Death by E2F-Dependent Gene Repression and Derepression , 2001, Neuron.

[35]  P. Gregory,et al.  Histone acetylation and chromatin remodeling. , 2001, Experimental cell research.

[36]  C. Allis,et al.  Histone acetyltransferases. , 2001, Annual review of biochemistry.

[37]  R. Bowser,et al.  Hyperphosphorylation of the retinoblastoma gene product and altered subcellular distribution of E2F-1 during Alzheimer's disease and amyotrophic lateral sclerosis. , 2001, Journal of Alzheimer's disease : JAD.

[38]  D. Johnson,et al.  p21WAF1 Prevents Down-modulation of the Apoptotic Inhibitor Protein c-IAP1 and Inhibits Leukemic Apoptosis , 2000, Molecular medicine.

[39]  J. Ikeda,et al.  Cyclin-dependent kinases as a therapeutic target for stroke. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Marks,et al.  Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  K. Abe,et al.  Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion , 2000, Neuropathology and applied neurobiology.

[42]  S. Kern,et al.  A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. , 2000, Cancer research.

[43]  Jon W. Johnson,et al.  Persistent Activation of ERK Contributes to Glutamate-induced Oxidative Toxicity in a Neuronal Cell Line and Primary Cortical Neuron Cultures* , 2000, The Journal of Biological Chemistry.

[44]  C. Sen,et al.  Molecular Basis of Vitamin E Action , 2000, The Journal of Biological Chemistry.

[45]  Hong Liu,et al.  Activation of Apoptosis Signal-Regulating Kinase 1 (ASK1) by Tumor Necrosis Factor Receptor-Associated Factor 2 Requires Prior Dissociation of the ASK1 Inhibitor Thioredoxin , 2000, Molecular and Cellular Biology.

[46]  W. El-Deiry,et al.  p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. , 2000, Biochemical and biophysical research communications.

[47]  D. Cohen,et al.  Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects* , 1999, The Journal of Biological Chemistry.

[48]  P. Marks,et al.  Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.

[49]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[50]  Hengyi Xiao,et al.  Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells , 1999, Journal of cellular biochemistry.

[51]  K. Miyazono,et al.  Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation , 1999, The EMBO journal.

[52]  M. Miura,et al.  Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21 , 1999, Oncogene.

[53]  S. Love Oxidative Stress in Brain Ischemia , 1999, Brain pathology.

[54]  K. Nakayama,et al.  Cip/Kip cyclin‐dependent kinase inhibitors: brakes of the cell cycle engine during development , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[55]  David S. Park,et al.  Cyclin-dependent Kinases Participate in Death of Neurons Evoked by DNA-damaging Agents , 1998, The Journal of cell biology.

[56]  D. Baltimore,et al.  Activation of apoptosis signal-regulating kinase 1 (ASK1) by the adapter protein Daxx. , 1998, Science.

[57]  M. Miura,et al.  Resistance to Fas-mediated apoptosis: activation of Caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP , 1998, Oncogene.

[58]  Y. Gotoh,et al.  Reactive Oxygen Species- and Dimerization-induced Activation of Apoptosis Signal-regulating Kinase 1 in Tumor Necrosis Factor-α Signal Transduction* , 1998, The Journal of Biological Chemistry.

[59]  David S. Park,et al.  Multiple Pathways of Neuronal Death Induced by DNA-Damaging Agents, NGF Deprivation, and Oxidative Stress , 1998, The Journal of Neuroscience.

[60]  Y. Gotoh,et al.  Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. , 1998, The Journal of biological chemistry.

[61]  K. Miyazono,et al.  Molecular cloning and characterization of the mouse apoptosis signal-regulating kinase 1. , 1997, Biochemical and biophysical research communications.

[62]  P. Maher,et al.  A Role for 12-lipoxygenase in Nerve Cell Death Caused by Glutathione Depletion , 1997, Neuron.

[63]  David S. Park,et al.  G1/S Cell Cycle Blockers and Inhibitors of Cyclin-Dependent Kinases Suppress Camptothecin-Induced Neuronal Apoptosis , 1997, The Journal of Neuroscience.

[64]  S H Kim,et al.  Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. , 1997, European journal of biochemistry.

[65]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[66]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.

[67]  E. Choi,et al.  A non-enzymatic p21 protein inhibitor of stress-activated protein kinases , 1996, Nature.

[68]  David S. Park,et al.  Inhibitors of Cyclin-dependent Kinases Promote Survival of Post-mitotic Neuronally Differentiated PC12 Cells and Sympathetic Neurons (*) , 1996, The Journal of Biological Chemistry.

[69]  K. Walsh,et al.  Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis , 1996, The Journal of cell biology.

[70]  James Brugarolas,et al.  Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.

[71]  G. Hannon,et al.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD , 1995, Science.

[72]  E. Lees Cyclin dependent kinase regulation. , 1995, Current opinion in cell biology.

[73]  Z. Su,et al.  Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. , 1994, Oncogene.

[74]  C. Guillouf,et al.  Induction of p21 (WAF-1/CIP1) during differentiation. , 1994, Oncogene.

[75]  J. Blow,et al.  Inhibition of cyclin-dependent kinases by purine analogues. , 1994, European journal of biochemistry.

[76]  T. Murphy,et al.  Rapid Communication: Oxidative Stress Induces Apoptosis in Embryonic Cortical Neurons , 1994, Journal of neurochemistry.

[77]  Barry Halliwell,et al.  Reactive Oxygen Species and the Central Nervous System , 1992, Journal of neurochemistry.

[78]  T. Murphy,et al.  Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents. , 1990, Brain research. Developmental brain research.

[79]  T. Murphy,et al.  Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[80]  T. Murphy,et al.  Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress , 1989, Neuron.

[81]  S. Heinemann,et al.  Clonal cell lines from the rat central nervous system , 1974, Nature.